Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without ...

HCL uniformly harbors a BRAF mutation that is not present in other B-cell malignancies. Hairy cell leukemia (HCL) is an indolent B-cell lymphoproliferative disorder that responds to several highly ...

This study provides a comprehensive review of both established and emerging prognostic markers in chronic lymphocytic leukemia (CLL), and their role in predicting disease, treatment response, and ...

Acute lymphoblastic leukemia (ALL) is a type of blood cancer that predominantly affects children. Thanks to improvements in treatments, survival rates for ALL have risen dramatically, now exceeding 90 ...

Pacific Peoples' Experiences of Cancer and Its Treatment in Aotearoa New Zealand Through Talanoa: A Qualitative Study of Samoan and Tongan Participants Acute leukemia is a group of hematologic ...

A graphic showing, top to bottom, how DNA aptamers target two specific markers on a leukemia stem cell’s surface, enter the cell and deliver anticancer drugs, resulting in death of the cancer cell.

A pioneering study offers new insights into how leukemia begins—and could open the door to predicting and preventing the disease. A new study led by Children’s Hospital Los Angeles (CHLA) has linked ...